Literature DB >> 18348773

The anti-oxidant defence response in individuals with the indeterminate form of Chagas disease (American trypanosomiasis).

R Pérez-Fuentes1, E Torres-Rasgado, H Salgado-Rosas, I Zamora-Ginez, M C Sánchez-Guillén.   

Abstract

In previous studies in animal models, Trypanosoma cruzi-induced oxidative stress and damage have sometimes been controlled by the host's anti-oxidant defence responses. The role of the anti-oxidant defence responses, such as the activities of the anti-oxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase (SOD), in protection against inflammation and damage have now been investigated in humans infected with T. cruzi. The subjects were 32 asymptomatic but seropositive individuals with the indeterminate form of Chagas disease, 18 symptomatic and seropositive patients with the chronic disease, and 50 seronegative and apparently healthy controls. The inflammatory process was explored using serum concentrations of tumour necrosis factor (TNF) and NO. The serum concentrations of GPx in the patients in the indeterminate phase of infection were similar to those in the controls but much higher than those in the chronic cases (P=0.001). The serum concentrations of SOD in the patients in the indeterminate phase of infection were not only significantly higher than those in the cases of chronic Chagas disease (P=0.0004) but also significantly higher than those in the controls (P<0.001). The seropositive subjects had significantly higher serum concentrations of TNF and NO than the controls (P<0.01 for each) and the cases of chronic Chagas disease had significantly higher serum concentrations of TNF and NO than the subjects with the indeterminate form of the disease (P<0.01 for each). It therefore appears that the host's anti-oxidant defence responses (at least in terms of elevated concentrations of SOD) may inhibit inflammation during the indeterminate phase of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348773     DOI: 10.1179/136485908X267858

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  5 in total

1.  Cloning, mRNA expression, and recombinant expression of peptidoglycan recognition protein II gene from large yellow croaker (Pseudosciaena crocea).

Authors:  Yong Mao; Jun Wang; Zhiwen Zhang; Shaoxiong Ding; Yongquan Su
Journal:  Mol Biol Rep       Date:  2010-03-28       Impact factor: 2.316

Review 2.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

3.  Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease.

Authors:  Amanda Fortes Francisco; Paula Melo de Abreu Vieira; Jerusa Marilda Arantes; Maisa Silva; Maria Lúcia Pedrosa; Silvana Maria Elói-Santos; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Márcio Sobreira Silva Araújo; Washington Luiz Tafuri; Cláudia Martins Carneiro
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

4.  Metallothionein-1 and nitric oxide expression are inversely correlated in a murine model of Chagas disease.

Authors:  Martha Elba Gonzalez-Mejia; Enrique Torres-Rasgado; Leonardo M Porchia; Hilda Rosas Salgado; José-Luis Totolhua; Arturo Ortega; Luisa Clara Regina Hernández-Kelly; Guadalupe Ruiz-Vivanco; Blanca G Báez-Duarte; Ricardo Pérez-Fuentes
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-02-17       Impact factor: 2.743

Review 5.  Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder.

Authors:  Eduardo Duarte-Silva; Michael Maes; Danielle Macedo; Wilson Savino; Christina Alves Peixoto
Journal:  Transl Psychiatry       Date:  2020-12-02       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.